• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN 3.5FR URETHANE UMB CATH; CATHETER, UMBILICAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN 3.5FR URETHANE UMB CATH; CATHETER, UMBILICAL ARTERY Back to Search Results
Model Number 8888160333
Device Problems Material Too Rigid or Stiff (1544); Material Split, Cut or Torn (4008)
Patient Problem Blood Loss (2597)
Event Date 02/25/2020
Event Type  Injury  
Event Description
The customer reported that the staff was loosening some sutures to remove the umbilical arterial line, but blood started coming out.While pulling the line out, it snapped in half.They grabbed the end of the line before it went into the baby and was able to remove the entire line.It was noted the piece that was inside the baby was stiffer than the rest of the line.Additional information was received from the customer stating that there was approximately 20 ml of blood loss.Prbc transfusion 30mls/kg was required for additional treatment.The baby is currently doing well.
 
Manufacturer Narrative
H 3: evaluation summary: a device history record (dhr) review revealed no discrepancies that may have contributed to a complaint of this failure mode.All quality assurance testing performed during manufacturing was acceptable.The quality assurance review of the visual, physical and dimensional evaluation results indicated that the product met specification requirements.In addition, all dhrs are reviewed for accuracy prior to product release.One catheter was received for analysis and investigation.Visual inspection of the sample showed signs of use.The catheter showed a clean cut at the end, and it seems to be manipulated.The event reported was confirmed.An ishikawa diagram was used to determine the potential causes for this event.It is important to consider that the instructions for use warn to exercise caution when using sharp instruments near the catheter.It warns to not use instruments with sharp or rough edges directly on the catheter since even a minor cut could break the catheter.Based on the available information this potential cause could not be discarded.100% of the catheters are submitted to a pressure testing.The cuts or damage of the catheter that was found during sample evaluation would be detected in this step.The most probable root cause can be considered as damage likely caused during use, due to manipulation.This complaint has not been confirmed as a manufacturing related issue.No trends or triggers have been found; therefore, a corrective and preventive action (capa) is not deemed necessary at this time.This complaint will be used for tracking and trending purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
3.5FR URETHANE UMB CATH
Type of Device
CATHETER, UMBILICAL ARTERY
Manufacturer (Section D)
COVIDIEN
edificio b20 calle #2 zona fra
alajuela
CS 
MDR Report Key9772161
MDR Text Key188819936
Report Number3009211636-2020-00689
Device Sequence Number1
Product Code FOS
UDI-Device Identifier20884527005113
UDI-Public20884527005113
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/28/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number8888160333
Device Catalogue Number8888160333
Device Lot Number1921900150
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/26/2020
Patient Sequence Number1
Patient Outcome(s) Other;
-
-